RE:RE:RE:RE:TS buys moreSo you would do well to read all their news releases for the last year or so on their website but essentially they have a stem cell treatment that they have proven with a bunch of small scale trials to save peoples limbs in the case of reduced blood flow to extremeties called CLI also this treatment has been shown to effectively regenerate damaged heart tissues. So this bigger trial for CLI has been ongoing for years but because of a string of sh1t CEOs and a licensee who was essentially trying to steal the IP, it has taken until now to sort out all their legal problems. Now we finally have the data and once they analyze it, and it shows what we all suspect it will (great efficacy for a currently uncurrable condition) then the stock will naturally rise to reflect the treatments much larger chance of becoming a lucrative medicine. Today is a good day but the market needs further convincing so i am waiting for the phase 2 results which shouldnt be far off. Good luck man!